Maruyama K - Search Results

1

SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.

Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M. Ilkiw R, et al. Among authors: maruyama k. Circ Res. 1989 Apr;64(4):814-25. doi: 10.1161/01.res.64.4.814. Circ Res. 1989. PMID: 2495195

2

Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.

Maruyama K, Ye CL, Woo M, Venkatacharya H, Lines LD, Silver MM, Rabinovitch M. Maruyama K, et al. Am J Physiol. 1991 Dec;261(6 Pt 2):H1716-26. doi: 10.1152/ajpheart.1991.261.6.H1716. Am J Physiol. 1991. PMID: 1836309

3

Intralipid effect on normal and hypoxic remodeled rat pulmonary vasculature.

Ilkiw R, Maruyama K, Rabinovitch M. Ilkiw R, et al. Among authors: maruyama k. Am J Physiol. 1988 Dec;255(6 Pt 2):H1499-508. doi: 10.1152/ajpheart.1988.255.6.H1499. Am J Physiol. 1988. PMID: 2974251

4

Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.

Rabinovitch M, Mullen M, Rosenberg HC, Maruyama K, O'Brodovich H, Olley PM. Rabinovitch M, et al. Among authors: maruyama k. Am J Physiol. 1988 Mar;254(3 Pt 2):H500-8. doi: 10.1152/ajpheart.1988.254.3.H500. Am J Physiol. 1988. PMID: 3348429

5

Expression and mutation of Ca2+ ATPases of the sarcoplasmic reticulum.

Maruyama K, Clarke DM, Fujii J, Loo TW, MacLennan DH. Maruyama K, et al. Cell Motil Cytoskeleton. 1989;14(1):26-34. doi: 10.1002/cm.970140107. Cell Motil Cytoskeleton. 1989. PMID: 2531042 Review. No abstract available.

6

Functional consequences of alterations to amino acids located in the catalytic center (isoleucine 348 to threonine 357) and nucleotide-binding domain of the Ca2+-ATPase of sarcoplasmic reticulum.

Maruyama K, Clarke DM, Fujii J, Inesi G, Loo TW, MacLennan DH. Maruyama K, et al. J Biol Chem. 1989 Aug 5;264(22):13038-42. J Biol Chem. 1989. PMID: 2526811 Free article.

7

Functional consequences of glutamate, aspartate, glutamine, and asparagine mutations in the stalk sector of the Ca2+-ATPase of sarcoplasmic reticulum.

Clarke DM, Maruyama K, Loo TW, Leberer E, Inesi G, MacLennan DH. Clarke DM, et al. Among authors: maruyama k. J Biol Chem. 1989 Jul 5;264(19):11246-51. J Biol Chem. 1989. PMID: 2567733 Free article.

8

Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation.

Fujii J, Maruyama K, Tada M, MacLennan DH. Fujii J, et al. Among authors: maruyama k. J Biol Chem. 1989 Aug 5;264(22):12950-5. J Biol Chem. 1989. PMID: 2502544 Free article.

9

Co-expression of slow-twitch/cardiac muscle Ca2(+)-ATPase (SERCA2) and phospholamban.

Fujii J, Maruyama K, Tada M, MacLennan DH. Fujii J, et al. Among authors: maruyama k. FEBS Lett. 1990 Oct 29;273(1-2):232-4. doi: 10.1016/0014-5793(90)81092-3. FEBS Lett. 1990. PMID: 2146166 Free article.

10

Mutation of aspartic acid-351, lysine-352, and lysine-515 alters the Ca2+ transport activity of the Ca2+-ATPase expressed in COS-1 cells.

Maruyama K, MacLennan DH. Maruyama K, et al. Proc Natl Acad Sci U S A. 1988 May;85(10):3314-8. doi: 10.1073/pnas.85.10.3314. Proc Natl Acad Sci U S A. 1988. PMID: 2966962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,906 results

Search Page

Filters